Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2012
06/21/2012US20120156263 Ursodeoxycholic Acid-Synthetic Hydrotalcite-Eudragit Hybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the Same
06/21/2012US20120156261 Disintegrating particle composition and orally rapidly disintegrating tablet
06/21/2012US20120156260 Prodrugs Containing an Aromatic Amine Connected By an Amido Bond to a Linker
06/21/2012US20120156259 Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels
06/21/2012US20120156258 Adjuvant or pharmaceutical preparation for transdermal or transmucosal administration
06/21/2012US20120156257 Method for the preparation of nanoparticles
06/21/2012US20120156256 Nanoparticles having at least one active ingredient and at least two polyelectrolytes
06/21/2012US20120156255 Drug eluting patch for the treatment of localized tissue disease or defect
06/21/2012US20120156254 Recombinant laminin-521
06/21/2012US20120156253 Enzyme Treatment of Foodstuffs for Celiac Sprue
06/21/2012US20120156252 Method of producing microbeads
06/21/2012US20120156251 Cationic oil-in-water emulsions
06/21/2012US20120156250 Compositions and methods for cardiac therapy
06/21/2012US20120156144 Foamable Compositions, Kits and Methods for Hyperhidrosis
06/21/2012US20120156143 Dosage forms of plant-derived cathartics
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012US20120153519 Method of Making a Soft Gel Capsule Comprising CoQ-10 Solubilized in a Monoterpene
06/21/2012US20120152262 Apparatus and method for moving and activating an active agent
06/21/2012DE112010000006T5 Verfahren zur Herstellung von nano-dispergierten high-all-trans-Carotinoid-Mikrokapseln Process for the preparation of nano-dispersed high-all-trans carotenoid microcapsules
06/21/2012CA2821886A1 Solid compositions comprising a glp-1 agonist and a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid
06/21/2012CA2821805A1 Controlled release oral dosage forms of poorly soluble drugs and uses thereof
06/21/2012CA2821799A1 Dry granulated cell culture media
06/21/2012CA2821141A1 Nanoparticles comprising at least one active agent and at least two polyelectrolytes
06/21/2012CA2821138A1 Process for preparing nanoparticles of two polyamino acids of opposite charge, one of the two of which is in charge surplus
06/21/2012CA2821122A1 Delivery of functional compounds
06/21/2012CA2819581A1 New particle stabilized emulsions and foams
06/21/2012CA2819167A1 Pharmaceutical compositions comprising alisporivir
06/21/2012CA2819137A1 Wear resistant antimicrobial compositions and methods of use
06/21/2012CA2819108A1 Pharmaceutical compositions of selective factor xa inhibitors for oral administration
06/21/2012CA2817461A1 Transdermal therapeutic system for administering an active substance
06/21/2012CA2787598A1 Irradiated biodegradable polymer microparticles
06/21/2012CA2787164A1 Compound sea cucumber product, preparation method, and dosage forms thereof
06/20/2012EP2465540A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465539A1 Disintegrating particle composition and orally rapidly disintegrating tablet
06/20/2012EP2465537A1 Microspheres comprising ONO-1301
06/20/2012EP2465512A1 Pharmaceutical composition for suppressing pain
06/20/2012EP2465503A1 Pharmaceutical solution of cetirizine hydrochloride
06/20/2012EP2465497A1 Pharmaceutical suspension composition
06/20/2012EP2465496A1 Anti-acidosis pharmaceutical composition
06/20/2012EP2465495A1 Tablet that disintegrates rapidly in the mouth and that contains two or more types of particles
06/20/2012EP2465494A2 Injectable composition containing hydroxychloroquine for local administration for treating cancer
06/20/2012EP2465493A1 Topical compositions
06/20/2012EP2465492A1 Compositions comprising sphingosine I phosphate (sip) receptor modulators
06/20/2012EP2464644A1 Solid oral formulations and crystalline forms of an inhibitor of apoptosis protein
06/20/2012EP2464388A1 Particulate hyaluronic acid formulations for cellular delivery of bioactive agents
06/20/2012EP2464387A2 Deuterated water and riboflavin solution for extending singlet oxygen lifetimes in treatment of ocular tissue and method for use
06/20/2012EP2464385A2 Photochemical internalization method
06/20/2012EP2464384A2 Photosensitizing compositions
06/20/2012EP2464373A1 Method for modulating the pharmacodynamic effect of orally administered guanylate cyclase receptor agonists
06/20/2012EP2464358A2 Improved pharmacokinetics of s-adenosylmethionine formulations
06/20/2012EP2464346A1 Treatment of cystic fibrosis using calcium lactate, leucine and sodium chloride in a respiraple dry powder
06/20/2012EP2464344A2 Pharmaceutical tablet comprising rosuvastatin calcium
06/20/2012EP2464343A1 Ophthalmic drug delivery system containing phospholipid and cholesterol
06/20/2012EP2464342A2 Novel pharmaceutical formulations against drug misuse
06/20/2012EP2464341A2 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/20/2012EP2464340A2 Pharmaceutical compositions with tetrabenazine
06/20/2012EP2464339A2 Steroid solvates
06/20/2012EP2464338A1 Dry powder inhaler formulations
06/20/2012EP2464337A1 Pharmaceutical composition and administrations thereof
06/20/2012EP2464336A2 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
06/20/2012EP2464335A1 Pharmaceutical composition including a dha ester to be parenterally administered
06/20/2012EP2464334A1 Compositions and methods for treating fungal infection of the nail
06/20/2012EP2464333A2 Floating microgranules
06/20/2012EP2464332A1 Storage-stable formulation of paracetamol in aqueous solution
06/20/2012EP2464331A1 Stabilised particles comprising 5-methyl-(6s)-tetrahydrofolate
06/20/2012EP2464330A1 Oral care compositions containing human recombinant interleukin-1
06/20/2012EP2464234A1 Methods for iontophoretically treating nausea and migraine
06/20/2012EP2464229A1 Use of 4-aminopyridine to improve neuro-cognitive and/or neuro-psychiatric impairment in patients with demyelinating and other nervous system conditions
06/20/2012EP2464224A1 Methods for drug delivery comprising unfolding and folding proteins and peptide nanoparticles
06/20/2012EP2303233B1 Solid oral dosage form containing anti-platelet agent clopidogrel and method for the preparation thereof
06/20/2012EP2125076B1 Spray administration of compositions including active agents such as peptides to the gastrointestinal tract
06/20/2012EP1902718B1 Active foam
06/20/2012EP1901712B1 Therapeutic sclerosing foam made preferably from xenon
06/20/2012EP1890678B1 Therapeutic sclerosing foam containing xenon
06/20/2012EP1852130B1 Medicine for external application containing anti-inflammatory agent and soy lecithin
06/20/2012EP1832288B1 Stable granular pharmaceutical composition of solifenacin or its salt
06/20/2012EP1763374B1 In situ hardening paste, its manufacturing and use
06/20/2012EP1734938B1 Insulin highly respirable microparticles
06/20/2012EP1729745B1 Method for producing cs particles and microcapsules using porous templates, cs particles and microcapsules, and the use thereof
06/20/2012EP1694295B1 Pharmaceutical oral dosage form comprising a non-steroidal anti-inflammatory drug, and having good palatability
06/20/2012EP1562559B1 Bio-degradable colloid particles, in particular for pulmonary applications
06/20/2012EP1467705B1 Therapeutic agent delivery tampon
06/20/2012EP1390016B2 Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
06/20/2012EP1280557B1 Method for the preparation of polymeric micelle via phase separation of block copolymer
06/20/2012CN202277522U 一种无糖型双黄连口服液的制备装置 Preparation means of a sugar-free Shuanghuanglian
06/20/2012CN1910217B Biogradable multi-block co-polymers
06/20/2012CN1879661B Use of nocardia rubra cell wall skeleton in preparation of medicine for resisting mycotic infection
06/20/2012CN1407884B Controlled release hydrocodone formulations
06/20/2012CN102510752A Novel pharmaceutical composition comprising a macrolide immunosuppressant drug
06/20/2012CN102507767A Alprostadil and quality standard of preparation thereof
06/20/2012CN102504988A A solid particulate laundry detergent composition comprising perfume particle
06/20/2012CN102504280A Method for preparing biofilm-imitated vesicle structure by utilizing modified hyper-branched polymer
06/20/2012CN102504018A Melittin pamoate capable of being continuously released and preparation agent thereof
06/20/2012CN102499978A Cataplasm for treating hyperplasia of mammary glands
06/20/2012CN102499975A Traditional Chinese medicine compound externally used paste for treating mumps
06/20/2012CN102499971A Sugar-free brain-nourishing tablet for treating cardiovascular and cerebrovascular diseases and preparation method thereof
06/20/2012CN102499960A Method for improving uniformity of strychnine in nux vomica powder of bone and tendon pill capsules
06/20/2012CN102499956A Plaster for burns and scalds and preparation method thereof
06/20/2012CN102499951A Chinese medicinal composition for treating laryngitis and preparation method thereof
06/20/2012CN102499949A Ointment for treating chapped hands and feet
1 ... 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 ... 2991